Sophie Madison Bilik

Ms. Sophie Madison Bilik

Dermatology, University of Miami Miller School of Medicine, Miami, Florida, USA
orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2024 in JID Innovations
Verified
Journal Article
Open access
LSLindsey G. Siegfried
Lindsey G. Siegfried
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
JBJamie Burgess
Jamie Burgess
PCPaola Catanuto
Paola Catanuto
IJIvan Jozic
Ivan Jozic
MTMarjana Tomic-Canic
Marjana Tomic-Canic
Advancements in pathology have given rise to software applications intended to minimize human error and improve efficacy of image analysis. Still, the subjectivity of image quantification performed manually and the limitations of the most ubiquitous tissue stain analysis software requiring parameters tuned by the observer, reveal the need for a highly accurate, automated nuclear quantification software specific to immunohistochemistry, with improved precision and efficiency compared with the methods currently in use. We present a method for the quantification of immunohistochemical biomarkers in keratinocyte nuclei proposed to overcome these limitations, contributing sensitive shape-focused segmentation, accurate nuclear detection, and automated device-independent color assessment, without observer-dependent analysis parameters.

9 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
TGTammy Gonzalez
Tammy Gonzalez
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
OBOlivia M. Burke
Olivia M. Burke
IPIrena Pastar
Irena Pastar
Gil YosipovitchGil Yosipovitch
Gil Yosipovitch
Chronic itch is a debilitating condition characterized by persistent pruritus lasting more than six weeks, significantly impairing quality of life. While the role of the immune system and neural circuits in itch is increasingly understood, the contribution of the skin microbiome, especially in non-atopic itch disorders, remains underexplored. This review synthesizes emerging evidence on how microbial dysbiosis contributes to chronic pruritus through multiple molecular pathways: disruption of skin barrier integrity, modulation of neuroimmune signaling axes, and direct activation of pruriceptors. We highlight recent studies identifying microbiome shifts in prurigo nodularis (PN) and lichen simplex chronicus (LSC), independent of atopic dermatitis (AD). We also evaluate advances in biologics and small-molecule therapeutics, exploring how targeted immune modulation may restore microbial balance and alleviate neuroinflammation. A systems biology approach integrating microbial genomics, neurobiology, and host immunity is critical to unraveling the complex interplay between host and microbes in chronic itch, particularly in understudied non-atopic conditions that disproportionately affect vulnerable populations.

1 November 2025 in Wound Repair and Regeneration
Verified
Journal Article
Open access
OBOlivia Burke
Olivia Burke
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
ARAna Restrepo
Ana Restrepo
JGJulio Garcia
Julio Garcia
ZFZachary J. Frischholz
Zachary J. Frischholz
SEScott A. Elman
Scott A. Elman
Pressure injuries are a major source of morbidity in critically ill patients, and early recognition is particularly difficult in patients with darker skin tones where erythema may be missed. This prospective study evaluated thermographic imaging with the Wound Scout in 32 patients (40 wound encounters) admitted to the ICU. Abnormal temperature, defined as > ±1.1°C, was significantly associated with deep tissue pressure injury (DTPI) diagnosis, with an odds ratio of 6.1 (95% CI 1.2–36.6), sensitivity of 83% and positive predictive value of 74%. Wound Scout changed the diagnosis in 25% of encounters, most often in sacral wounds where visual inspection is limited. Performance was consistent across Fitzpatrick skin types, supporting its utility in skin of colour. Longitudinal data from a small subset ( n = 10) did not show predictive value for progression. Thermography offers an objective, equitable adjunct to clinical assessment that may improve early detection of pressure injuries.

18 November 2025 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
OBOlivia Burke
Olivia Burke
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
FHFiona M. Hanly‐Jorda
Fiona M. Hanly‐Jorda
RKRobert S. Kirsner
Robert S. Kirsner
PRPaulo Romanelli
Paulo Romanelli

30 September 2025 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
OBOlivia Burke
Olivia Burke
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
AMAndrea Maderal
Andrea Maderal
SEScott A. Elman
Scott A. Elman

12 November 2025 in bioRxiv
Verified
Preprint
Open access
Sophie Madison BilikSophie Madison Bilik
Sophie Madison Bilik
CDCaroline Dodson
Caroline Dodson
KRKatelyn Rivas
Katelyn Rivas
NBNathan Balukoff
Nathan Balukoff
AGAnthony Griswold
Anthony Griswold
RSRivka Stone
Rivka Stone
Diabetic foot ulcers (DFUs) are a common and debilitating complication of diabetes, and amputations from non-healing ulcers carry high morbidity and mortality. A critical need exists for biomarkers that can identify healing potential early and guide targeted interventions. To address this, we applied an integrated multi-omics approach across four patient cohorts comprising 51 DFUs (29 Healing, 22 Non-healing). Bulk RNA-sequencing revealed marked activation of Th1 and Th2 pathways (activation z-score +4.8, p = 3.8×10⁻¹⁵), and immune cell deconvolution predicted higher proportions of T cell populations in Healers. Spatial proteomics in a second cohort identified elevated CD3⁺ T cell density and selective enrichment of PD-1 and PD-L1 expression in vascular niches of the papillary dermis in Healers (p < 0.001). Flow cytometry in a third cohort further demonstrated higher proportions of CD3⁺PD-1⁺ and CD3⁺PD-L1⁺ T cells in Healers compared with Non-healers. Single-cell RNA-sequencing from a fourth cohort showed upregulation of PD-1 and PD-L1 within CD4⁺ T cells from Healers. Complementary immunofluorescence and serological profiling confirmed that both PD-1 and PD-L1 are elevated in tissue and circulating serum of healing DFUs, supporting their potential use as systemic biomarkers. Taken together, vascular-enriched PD-1/PD-L1 signaling and T cell activation were observed in association with healing DFUs, supporting PD-1/PD-L1 as candidate biomarkers in both tissue and blood with potential translational relevance for predicting DFU outcomes and informing precision therapies.